JAMES TEASDALL: Open Payments
NPI 1881357796 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 27 payments from 11 companies in 2025. Trend: 2023 $1,908 · 2024 $771 · 2025 $633
Food & beverage: $598Education: $35
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 12 | $268 |
| Janssen Biotech, Inc. | 3 | $84 |
| ABBVIE INC. | 2 | $40 |
| Endo USA, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| UROGEN PHARMA, INC. | 1 | $30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $28 |
Products named: PROVENGE, ERLEADA, BOTOX, XIAFLEX, IMFINZI, LYNPARZA, JELMYTO, YONSA.
Industry payments across NC — which companies pay providers there.
